XML 66 R52.htm IDEA: XBRL DOCUMENT v3.22.2.2
Note 6 - Contingent Liability (Details Textual) - USD ($)
1 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2021
Sep. 30, 2021
Apr. 19, 2019
Dec. 20, 2018
May 31, 2022
Apr. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Jul. 31, 2021
Apr. 30, 2019
Jun. 30, 2022
Sep. 30, 2022
Dec. 31, 2022
Sep. 30, 2022
Sep. 30, 2021
Nov. 30, 2021
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability                           $ (8,473,999) $ 6,687,439  
Business Combination, Contingent Consideration, Liability, Noncurrent   $ 9,856,000                   $ 276,000   276,000 9,856,000  
Restricted Stock Units (RSUs) [Member] | Share-Based Payment Arrangement, Employee [Member]                                
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares)                               120,000
Restricted Stock Units (RSUs) [Member] | Share-Based Payment Arrangement, Employee [Member] | Minimum [Member]                                
Share-based Compensation Arrangement by Share-based Payment Award, Terms, Generated Net Sales, Amount                         $ 3,000,000      
Restricted Stock Units (RSUs) [Member] | Share-Based Payment Arrangement, Employee [Member] | Maximum [Member]                                
Share-based Compensation Arrangement by Share-based Payment Award, Terms, Generated Net Sales, Amount                         $ 8,000,000      
Share-Based Payment Arrangement, Option [Member]                                
Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Number of Shares Per Employee (in shares)           100,000                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Minimum Consumer Revenue Required           $ 12,000,000.0                    
Employee-related Liabilities, Total                       $ 0   $ 0    
Cure Based Development, Llc [Member] | Common Stock [Member]                                
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)                   15,250,000            
Business Acquisition, Equity Interest Issued or Issuable, Vesting Period (Year)                   5 years            
Business Acquisition, Equity Interest Issued or Issuable, Number of Additional Earnout Shares (in shares)         458,877   444,243 466,713   15,250,000 409,505 3,928,792        
Business Acquisition, Equity Interest Issued or Issuable, Number of Additional Earnout Shares, Expiration (Month)       60 months                        
Long-Term Debt, Gross                   $ 53,215,163            
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable     $ 53,215,163                          
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability         $ 90,792 17,718 $ 41,914 $ (366,841)                
Business Combination, Contingent Consideration, Liability, Current $ 405,000       $ 178,000 $ 198,000 325,000 405,000                
Business Acquisition, Equity Interest Issued or Issuable, Number of Remaining Earnout Shares Subject to Issuance (in shares)                       3,928,797   3,928,797    
Business Combination, Contingent Consideration, Liability, Noncurrent   9,440,000                   $ 276,000   $ 276,000 9,440,000  
Cure Based Development, Llc [Member] | Registered Common Stock [Member]                                
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)                   6,500,000            
Cure Based Development, Llc [Member] | Unregistered Common Stock [Member]                                
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)                   8,750,000       2,187,500    
Business Acquisition, Equity Interest Issued or Issuable, Vesting Period (Year)                   5 years            
Twenty Two Acquisition [Member] | Common Stock [Member]                                
Business Acquisition, Equity Interest Issued or Issuable, Number of Additional Earnout Shares (in shares)                 200,000              
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability (255,000) (73,561)         148,000             $ 13,000    
Business Combination, Contingent Consideration, Liability, Noncurrent $ 161,000 $ 416,000         $ 13,000 $ 161,000 $ 488,561     $ 0   $ 0 $ 416,000